Hypercoagulability in Kidney Transplant Recipients
ABSTRACTThrombosis remains an important complication after kidney transplantation. Outcomes for graft and deep vein thrombosis are not favorable. The majority of early kidney transplant failure in adults is due to allograft thrombosis. Risk stratification, early diagnosis, and appropriate intervention are critical to the management of thrombotic complications of transplant. In patients with end-stage renal disease, the prevalence of acquired risk factors for thrombosis is significantly high. Because of hereditary and acquired risk factors, renal transplant recipients manifest features of a chronic prothrombotic state. Identification of hereditary thrombotic risk factors before transplantation may be a useful tool for selecting appropriate candidates for thrombosis prophylaxis immediately after transplantation. Short-term anticoagulation may be appropriate for all patients after kidney transplantation..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:100 |
|---|---|
| Enthalten in: |
Transplantation - 100(2016), 4, Seite 719-726 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parajuli, Sandesh [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| RVK: |
|---|
| doi: |
10.1097/TP.0000000000000887 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC197478097X |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC197478097X | ||
| 003 | DE-627 | ||
| 005 | 20220222134614.0 | ||
| 007 | tu | ||
| 008 | 160609s2016 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1097/TP.0000000000000887 |2 doi | |
| 028 | 5 | 2 | |a PQ20160610 |
| 035 | |a (DE-627)OLC197478097X | ||
| 035 | |a (DE-599)GBVOLC197478097X | ||
| 035 | |a (PRQ)c1397-ceb581ca0b79f752962c791fad2006790552b0062ddd9898174f71190493efc00 | ||
| 035 | |a (KEY)0031140520160000100000400719hypercoagulabilityinkidneytransplantrecipients | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a XA 10000 |q AVZ |2 rvk | ||
| 084 | |a 44.65 |2 bkl | ||
| 100 | 1 | |a Parajuli, Sandesh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hypercoagulability in Kidney Transplant Recipients |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a ABSTRACTThrombosis remains an important complication after kidney transplantation. Outcomes for graft and deep vein thrombosis are not favorable. The majority of early kidney transplant failure in adults is due to allograft thrombosis. Risk stratification, early diagnosis, and appropriate intervention are critical to the management of thrombotic complications of transplant. In patients with end-stage renal disease, the prevalence of acquired risk factors for thrombosis is significantly high. Because of hereditary and acquired risk factors, renal transplant recipients manifest features of a chronic prothrombotic state. Identification of hereditary thrombotic risk factors before transplantation may be a useful tool for selecting appropriate candidates for thrombosis prophylaxis immediately after transplantation. Short-term anticoagulation may be appropriate for all patients after kidney transplantation. | ||
| 540 | |a Nutzungsrecht: Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. | ||
| 700 | 1 | |a Lockridge, Joseph B |4 oth | |
| 700 | 1 | |a Langewisch, Eric D |4 oth | |
| 700 | 1 | |a Norman, Douglas J |4 oth | |
| 700 | 1 | |a Kujovich, Jody L |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Transplantation |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1963 |g 100(2016), 4, Seite 719-726 |w (DE-627)129501905 |w (DE-600)208424-7 |w (DE-576)014903555 |x 0041-1337 |7 nnns |
| 773 | 1 | 8 | |g volume:100 |g year:2016 |g number:4 |g pages:719-726 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1097/TP.0000000000000887 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26413991 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | r | v | |a XA 10000 |
| 936 | b | k | |a 44.65 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 100 |j 2016 |e 4 |h 719-726 | ||